MHH researchers are developing a customisable glaucoma implant. It is designed to significantly reduce the risk of scarring and blindness.

Real-time data exchange: The telePIN network connects Clinical Departments and enables highly qualified remote treatment

An international Phase 2 clinical trial led by MHH demonstrates the beneficial effects of the microRNA blocker in severely damaged hearts.

The Center for Neuroendocrine Tumors at the Comprehensive Cancer Center Lower Saxony (CCC-N) receives ENETS certification. Patient involvement is a…

The ARREST study aims to map palliative care for prisoners and identify potential gaps and opportunities.

A 3.8-billion-year-old quantum machine controls our immune system: MHH research team discovers ancient mechanism that still works.

Prevention, early intervention, performance optimization, and post-accident treatment

MHH biochemist is researching alternatives to antibiotics and has received two million euros from the European Union.

A photo exhibition by Wolfgang Niess in the MHH art gallery offers the opportunity to immerse oneself in the world of the Venetian Carnival.

Between the lecture hall and the waiting list: When medical students teach their own transplant stories.